{"altmetric_id":414554,"counts":{"readers":{"mendeley":92,"citeulike":0,"connotea":0},"total":{"posts_count":12},"twitter":{"unique_users_count":10,"unique_users":["rincondesisifo","JIslamMedAssoc","JohnAGoodfellow","danypas","hmsilverman","The_Pillbook","Dr_AdrianMC","Neurology_OW","MS_Wisdom2","aymanfadel"],"posts_count":10},"wikipedia":{"unique_users_count":2,"unique_users":["en:7663818","en:50603"],"posts_count":2}},"selected_quotes":["(Lancet Neurol) Revisi\u00f3n del tratamiento oral de la esclerosis m\u00faltiple","Review: Oral treatments for MS. #multiplesclerosis","Promising new oral therapies emerging for multiple sclerosis."],"citation":{"abstract":"The armamentarium for the treatment of relapsing-remitting multiple sclerosis (RRMS) is increasing rapidly. Several oral treatments have shown benefit and will generate much interest because of the convenience of such administration. However, availability of convenient oral drugs will not necessarily translate into clinical effectiveness and safety. Here, we provide an interim report about the mechanisms of action, and efficacy and safety results that have been reported since January, 2010, for five new oral drugs. Additionally, we draw attention to issues that neurologists and patients will encounter when considering the use of new oral drugs.","abstract_source":"pubmed","altmetric_jid":"4f6fa4f73cf058f610002fd0","authors":["Joep Killestein","Richard A Rudick","Chris H Polman"],"doi":"10.1016\/s1474-4422(11)70228-9","first_seen_on":"2011-10-18T08:37:44+00:00","issns":["1474-4422"],"issue":"11","journal":"Lancet Neurology","last_mentioned_on":1365194491,"links":["http:\/\/www.thelancet.com\/journals\/laneur\/article\/PIIS1474-4422(11)70228-9\/abstract?rss=yes","http:\/\/www.thelancet.com\/journals\/laneur\/article\/PIIS1474-4422(11)70228-9\/abstract?elsca1=ETOC-NEUROLOGY&elsca2=email&elsca3=segment","http:\/\/www.thelancet.com\/journals\/laneur\/article\/PIIS1474-4422(11)70228-9\/fulltext","http:\/\/www.thelancet.com\/journals\/laneur\/article\/PIIS1474-4422%2811%2970228-9\/abstract","http:\/\/dx.doi.org\/10.1016\/S1474-4422(11)70228-9","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22014437"],"pdf_url":"http:\/\/download.thelancet.com\/pdfs\/journals\/laneur\/PIIS1474442211702289.pdf","pmid":"22014437","pubdate":"2011-11-01T00:00:00+00:00","publisher":"Elsevier","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Neurosciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1026","subjects":["neurology"],"title":"Oral treatment for multiple sclerosis.","type":"article","volume":"10","mendeley_url":"http:\/\/www.mendeley.com\/research\/oral-treatment-multiple-sclerosis-1"},"altmetric_score":{"score":12.55,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":12.55},"context_for_score":{"all":{"total_number_of_other_articles":5032959,"mean":5.9653559095836,"rank":379293,"this_scored_higher_than_pct":92,"this_scored_higher_than":4652794,"rank_type":"exact","sample_size":5032959,"percentile":92},"similar_age_3m":{"total_number_of_other_articles":71574,"mean":4.6217861763514,"rank":4899,"this_scored_higher_than_pct":93,"this_scored_higher_than":66669,"rank_type":"exact","sample_size":71574,"percentile":93},"this_journal":{"total_number_of_other_articles":1521,"mean":13.295669736842,"rank":375,"this_scored_higher_than_pct":75,"this_scored_higher_than":1145,"rank_type":"exact","sample_size":1521,"percentile":75},"similar_age_this_journal_3m":{"total_number_of_other_articles":36,"mean":4.0957142857143,"rank":6,"this_scored_higher_than_pct":83,"this_scored_higher_than":30,"rank_type":"exact","sample_size":36,"percentile":83}}},"demographics":{"poster_types":{"member_of_the_public":10},"users":{"twitter":{"cohorts":{"Members of the public":10}},"mendeley":{"by_status":{"Professor > Associate Professor":6,"Researcher":16,"Student  > Doctoral Student":3,"Student  > Ph. D. Student":8,"Student  > Postgraduate":11,"Other":17,"Student  > Master":12,"Student  > Bachelor":12,"Lecturer > Senior Lecturer":2,"Professor":5},"by_discipline":{"Engineering":2,"Medicine and Dentistry":55,"Neuroscience":7,"Psychology":2,"Immunology and Microbiology":2,"Economics, Econometrics and Finance":1,"Agricultural and Biological Sciences":12,"Biochemistry, Genetics and Molecular Biology":2,"Unspecified":8,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"mendeley":{"CO":1,"KR":1,"US":1,"IE":1,"BR":2,"RS":1,"ZA":2,"IT":1,"PT":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/rincondesisifo\/status\/126213761441873920","citation_ids":[414554],"posted_on":"2011-10-18T08:31:20+00:00","author":{"id_on_source":"rincondesisifo","tweeter_id":97940096},"tweet_id":"126213761441873920"},{"url":"http:\/\/twitter.com\/#!\/JIslamMedAssoc\/status\/128117258634526720","rt":["TheLancet"],"citation_ids":[414554],"posted_on":"2011-10-23T14:35:09+00:00","author":{"id_on_source":"JIslamMedAssoc","tweeter_id":86775166},"tweet_id":"128117258634526720"},{"url":"http:\/\/twitter.com\/#!\/JohnAGoodfellow\/status\/155699779073085440","citation_ids":[414554],"posted_on":"2012-01-07T17:18:14+00:00","author":{"name":"John Goodfellow","image":"https:\/\/pbs.twimg.com\/profile_images\/2747182900\/d0a2838d626ddd8ffaf0d856f26cae41_normal.png","id_on_source":"JohnAGoodfellow","tweeter_id":"234525571","geo":{"lt":null,"ln":null},"followers":23},"tweet_id":"155699779073085440"},{"url":"http:\/\/twitter.com\/#!\/danypas\/status\/126220045587193856","rt":["rincondesisifo"],"citation_ids":[414554],"posted_on":"2011-10-18T08:56:18+00:00","author":{"id_on_source":"danypas","tweeter_id":56293538},"tweet_id":"126220045587193856"},{"url":"http:\/\/twitter.com\/#!\/hmsilverman\/status\/126327265725394945","citation_ids":[414554],"posted_on":"2011-10-18T16:02:21+00:00","author":{"id_on_source":"hmsilverman","tweeter_id":1173374},"tweet_id":"126327265725394945"},{"url":"http:\/\/twitter.com\/#!\/The_Pillbook\/status\/126327259949834240","citation_ids":[414554],"posted_on":"2011-10-18T16:02:20+00:00","author":{"id_on_source":"The_Pillbook","tweeter_id":110904082},"tweet_id":"126327259949834240"},{"url":"http:\/\/twitter.com\/#!\/Dr_AdrianMC\/status\/126501149472866304","citation_ids":[414554],"posted_on":"2011-10-19T03:33:18+00:00","author":{"id_on_source":"Dr_AdrianMC","tweeter_id":194627064},"tweet_id":"126501149472866304"},{"url":"http:\/\/twitter.com\/#!\/Neurology_OW\/status\/126498235404660736","citation_ids":[414554],"posted_on":"2011-10-19T03:21:44+00:00","author":{"id_on_source":"Neurology_OW","tweeter_id":114597305},"tweet_id":"126498235404660736"},{"url":"http:\/\/twitter.com\/#!\/MS_Wisdom2\/status\/126769822670397441","citation_ids":[414554],"posted_on":"2011-10-19T21:20:55+00:00","author":{"id_on_source":"MS_Wisdom2","tweeter_id":115256317},"tweet_id":"126769822670397441"},{"url":"http:\/\/twitter.com\/#!\/aymanfadel\/status\/128117261994164225","rt":["TheLancet"],"citation_ids":[414554],"posted_on":"2011-10-23T14:35:10+00:00","author":{"id_on_source":"aymanfadel","tweeter_id":995831},"tweet_id":"128117261994164225"}],"wikipedia":[{"title":"Management of multiple sclerosis","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=536236986#altmetric_citation_172","license":"public","citation_ids":[414554],"posted_on":"2013-02-02T20:00:13+00:00","summary":"Several therapies for multiple sclerosis (MS) exist, although there is no known cure.","page_url":"http:\/\/en.wikipedia.org\/?curid=7663818","wiki_lang":"en","author":{"name":"Garrondo","url":"http:\/\/en.wikipedia.org\/wiki\/User:Garrondo"}},{"title":"Multiple sclerosis","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=548892000#altmetric_citation_295","license":"public","citation_ids":[414554],"posted_on":"2013-04-05T20:41:31+00:00","summary":"Multiple sclerosis (MS), also known as disseminated sclerosis or encephalomyelitis disseminata, is an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged.","page_url":"http:\/\/en.wikipedia.org\/?curid=50603","wiki_lang":"en","author":{"name":"Garrondo","url":"http:\/\/en.wikipedia.org\/wiki\/User:Garrondo"}}]}}